Facetime with Phil: Are Compounds Off-Label or Experimental?

The FDA approves drug ingredients for specific conditions in specific dosage forms. However, in workers’ compensation, it is not uncommon for FDA-approved drugs to be compounded into new, untested dosage forms that are intended for unapproved uses in pain management.

Join myMatrixx Chief Clinical Officer Phil Walls for this Facetime with Phil video blog as he discusses the potential dangers this poses to injured workers and why these types of drugs are not classified as off-label but could be considered experimental.

BACK TO ALL VIDEOS

OTHER VIDEOS IN THIS SERIES

DEFINING OFF-LABEL DRUG USE FDA’S NEW POSITION ON OFF-LABEL DRUG USE

OFF-LABEL VS. INVESTIGATIONAL DRUG USE OFF-LABEL DRUG USE: POTENTIAL IMPACT ON WORKERS’ COMPENSATION

INAPPROPRIATE WARNINGS FOR OPIOIDS